The Hajj, the pilgrimage to Mecca by millions of Muslims from around the world, is one of the largest gatherings of man on the face of the earth. This annual event took place just last month with relatively little fanfare from the news media, which is, from an epidemiological standpoint, a very good thing. Every year, public health officials wring their hands at the thought of possible outbreaks caused by the global pathogen du jour capitalizing upon the convergence of millions of worshipers in the Saudi Arabian desert. SARS stole the headlines in 2009, Middle Eastern Respiratory Virus or MERS had it last year, and Ebola seemed a likely contender for this calendar year.
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, continues to make inroads in the United States and physicians are both unprepared to diagnose and under equipped to treat cases of the disease in their patients.
Chagas is a rare disease in the United States and has typically been associated with immigration from Central and South America, where the disease is endemic. The dynamics of the disease are changing, however, and strong evidence continues to emerge indicating that local infection is occurring among the American population, particularly in the southern states.
Mining is low on the list of enviable occupations. The hazards one faces when plying one of humanity’s most ancient professions, burrowing deep into the earth to harvest its hidden treasures in the form of precious stones and metals, range from grungy to downright gruesome. The occupation is widely considered to be one of the world’s most dangerous, and it was only in the 1950s that the mining industry in the United States finally saw fatalities due to accidents dip under a thousand a year (1).
Rose-thorn disease sounds like a malady of lovesick teenagers, an illness of romance reserved for budding Romeos and Juliets swooning from their first forays into passion and lovesickness, an affliction arising from the shocking stick and sting of heartbreak. The sweet name of this malady, however, in no way belies the actual crustiness of its symptoms.
Microbes are the omnipresent yet frequently unacknowledged adversary on the battlefield. Though microscopic in size, their very macroscopic effects can decimate armies, foil the best planned war initiatives, and change the course of history.
In the period October 1980-May 1981, 5 young men, all active homosexuals, were treated for biopsy-confirmed Pneumocystis carinii pneumonia at 3 different hospitals in Los Angeles, California. Two of the patients died. All 5 patients had laboratory-confirmed previous or current cytomegalovirus (CMV) infection and candidal mucosal infection. Case reports of these patients follow.
Last week, the State Department performed a small but smart gesture towards countering the continued outbreak of the Ebola virus in West Africa by releasing a video featuring President Barack Obama speaking to the people of Liberia, Sierra Leone, Guinea, and Nigeria.
This may come as a total shock, but pure forms of illicit drugs can be hard to come by. Certain controlled substances are frequently adulterated, if not outright contaminated, by products that range from the household to the industrial to the pharmaceutical. Of course, some substances are more easily, frequently, and profitably adulterated than others: cocaine purchased on the retail level is on average 31%, well, not cocaine, while the purity of heroin on the street is even lower, resting around 65% (1).
Unbeknownst to many of the public, August was National Immunization Awareness Month. I know, I know: it’s been overshadowed by some very exotic and thrilling headliners this month. The Ebola epidemic blazing defiantly in West Africa. The jaw-dropping videos shown on Discovery Channel’s “Shark Week.” The ALS Ice Bucket Challenge clogging everyone’s social feeds. Vaccines are just not as sexy or as flamboyant as these issues. Truthfully, they’re a bit dull to talk about, not a topic you would tend to bring up at cocktail parties or at the water cooler. Read More
Just as we jetsetters and nomads wander the wide world’s winding roads and byways by foot, on horseback, atop a bicycle or packed into an automobile, so too do infectious diseases make use of our ever-improving networks of thoroughfares. They ride along in human bodies, their journeys fueled by our social mobility and contact, two factors unavoidably intensified anytime we embark upon a voyage. But as these pathogens travel new routes and encounter new bodies, they can change and mutate. Luckily for researchers, by examining commonly traveled routes where we once naively believed that only humans trod, the active evolution and epidemiology of a pathogen can be revealed, providing insight into the development and patterns of disease affecting mankind.